CVS Cancels Pharma-Funded Rx Reminders Citing New HIPAA Rule
by Joseph Conn

This article, posted May 6 in ModernHealthcare.com, explains that the CVS drugstore chain is discontinuing its practice of using data from its patient prescription drug records to mail prescription refill notices to customers on behalf of pharmaceutical manufacturers. The reason? A more stringent compensation provision in the omnibus patient privacy rule re-interpreting the Health Insurance Portability and Accountability Act.

The article notes that the Food Marketing Institute and the National Association of Chain Drug Stores have asked that HHS issue a clarification on the scope of the refill reminder provision of the rule.

See the complete article here (with free journal registration):
CVS Cancels Pharma-Funded Rx Reminders Citing New Rule

Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories
by J Demonceau, et al

Published in the April 2013 issue of Drugs, Demonceau and colleagues report on their meta-analysis of 79 randomized controlled trials in which adherence was assessed by electronically compiled drug dosing histories.The adherence-enhancing components were classified in 8 categories.

Of the 8 adherence-enhancing interventions tested, 2 had a statistically significant effect on patient medication adherence: an 8.7% increase in adherence when the intervention included an electronically monitored adherence feedback system, and a 5.6% increase when the intervention included a cognitive-educational component. In addition, the effect of interventions on adherence decreased by 1.1% each month.

See the complete article here:
Assessing Adherence Through Electronic Drug Dosing Histories

Primary Medication Non-Adherence after Discharge from a General Internal Medicine Service
by Brooks Fallis, et al

Published May 2 in PLoS One (Public Library of Science), the authors studied 232 older adults consecutively discharged from a general internal medicine service at a large urban teaching hospital to determine the prevalence of primary non-adherence and identify characteristics associated with primary non-adherence.

In total, 28% exhibited primary non-adherence (failure to fill an initial prescription) at 7 days after discharge, and 24% continued to exhibit primary non-adherence even 30 days after discharge. Overall, patients who were discharged to a nursing home had higher rates of primary non-adherence (43%) compared with those patients discharged to a home environment (26%).

See the complete article here:
Non-Adherence after Discharge from a General Medicine Service

Forward this issue of Loyalty Marketing Monthly to a colleague

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Does therapeutic class have any effect on patient persistency?

Yes! There are differences in persistency based solely on the therapeutic class. Generally, patients tend to be less persistent in taking medicines that treat conditions with milder symptoms or consequences.
Yet even in oncology, high co-pays increase abandonment.

In a 2011 PediatRx/Sermo survey of cancer specialists, 98% said at least some of their patients are using co-pay assistance programs for cancer-related prescription medications. Nearly 2 out of 3 said that 20% or more of their patients are using co-pay assistance programs, and 12% said 60-100% of their patients use co-pay assistance programs.

The battle to get patients to take a long-term view of treatment is one that pharmaceutical companies must continue to fight, and a co-pay assistance program can be a valuable aid in raising the chances of success.

Upcoming Loyalty/Adherence Conferences

ExL’s 4th Patient Adherence Conference AND 5th ePatient Connections Conference
Sep 16-17, 2013
Philadelphia, PA
Patient Adherence Summit

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

What PSKW Does

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Healthcare Payment Solutions

Attend “Co-pay Programs in the Spotlight: Top Controversies Affecting Marketers” at MM&M Virtual Summit, Wed, 4/24, 1:05 ET

At this year’s MM&M Virtual Summit, PSKW’s Chris Dowd will present a webinar focused on three of the top co-pay controversies affecting pharma marketers: What is the real goal of co-pay assistance programs?; What’s the best way to measure program ROI?; and What is the best co-pay offer?

The conference begins at noon ET on Wednesday, April 24, with a keynote address by Nancy Phelan, VP, Customer Strategy and Operations, Bristol-Myers Squibb. Chris’s talk on co-pay controversies follows immediately at 1:05 PM.

The MM&M Virtual Summit is a FREE online conference where some of the finest leaders and thinkers in healthcare marketing discuss and share strategies, observations, and insights on some of the key issues facing the industry.

Register here:  M&M Virtual Summit — Wednesday, April 24

A Text Messaging Intervention to Improve Heart Failure Self-Management After Hospital Discharge: Before-After Study
by Shantanu Nundy, et al

Published in March 2013 in Journal of Medical Internet Research, Nundy and colleagues assessed the feasibility and acceptability of a text message–based intervention in a largely African American and Medicaid-insured population with ADHF and explore its effects on self-management.

Participants strongly agreed that the program was easy to use (83%), reduced pills missed (66%), and decreased salt intake (66%). Maintenance (mean score 49 to 78, P=.003) and management (57 to 86, P=.002) improved at 4 weeks.

See the complete article here:  Text Messaging Intervention to Improve Self-Management

Review of book “Healthcare Relationship Marketing” by Ira Haimowitz, PhD
by Fadi Alkhateeb and Minh-Nguyen Do

Published in the current issue of the International Journal of Pharmaceutical and Healthcare Marketing, this review by Alkhateeb and Do refers to Haimowitz’s 212-page book as “remarkably well written, insightful and organized.” They observe that Haimowitz provides “extensive introductions into the basic frameworks with details explaining the design and measurement disciplines associated with relationship marketing.”

This appears to be a structured and well-organized book that would be a valuable addition to the library of any pharmaceutical marketer interested in loyalty marketing.

See the complete article here: Review of “Healthcare Relationship Marketing”

Forward this issue of Loyalty Marketing Monthly to a colleage

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Does the impact of high-deductible health plans show up in month-to-month patient out-of-pocket drug expense?

Yes! Every January we see an interesting phenomenon in our data. The average co-pay across most programs jumps between 10% and 20%. This has happened each of the last four years, and 2013 had the biggest increase yet. The spike typically takes 3-4 months to play out. We believe this illustrates the impact of high-deductible health plans. As the deductible resets each January, this subset of ‘insured’ patients actually has to pay full price for their prescriptions until their deductible is met. If these programs become more prevalent, we should see these yearly spikes continue to grow in magnitude. Some clients have begun to address this by instituting yearly benefit caps on our programs versus a set cap for each use.

Upcoming Loyalty/Adherence Conferences

MM&M’s Virtual Summit
April 24, 2013 — Noon ET
Register: MM&M Virtual Summit

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

EyeForPharma’s
10th Patient Summit USA
May 2-3, 2013
Philadelphia, PA
Patient Summit USA

What PSKW Does

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Healthcare Payment Solutions

Medication Adherence Issues In Patients: Focus on Cost
by Doreen Matsui

This March 2013 article in Clinical Audit provides a detailed and thorough summary of the most important cost implications of less than optimal medication adherence.

Matsui reports on numerous examples of published research in which poor medication adherence led to adverse health outcomes. She also describes in detail the increased health care costs that result from poor adherence. While noting certain exceptions, Matsui concludes that “improved adherence is often associated with lower total health care costs…”

The author takes special care in discussing the well-documented association between high patient out-of-pocket costs and poor adherence. She concludes with a useful explanation of the positive results seen with co-pay reduction programs and other financial incentives. With more than 100 citations, this publication has a rightful place in the library of anyone with an interest in adherence.

See the complete article here:  Medication Adherence Issues In Patients: Focus on Cost

Non-adherence in Type 2 Diabetes: Practical Considerations for Interpreting the Literature
by David Blackburn, Jaris Swidrovich, and Mark Lemstra

This March 2013 publication from Patient Preference and Adherence details the specific adherence challenges in patients with type 2 diabetes. The authors present a broad view of the patterns and predictors of non-adherence in these patients, and emphasize the point that no single intervention can eliminate non-adherence in this group.

Interestingly, the authors provide details of just one intervention that resulted in substantive increases in adherence and clinical success rates: patient cost reductions.

See the complete article here:  Non-adherence in Type 2 Diabetes

Web 2.0 Chronic Disease Self-Management for Older Adults: A Systematic Review
by Michael Stellefson, et al

Published in February 2013 in Journal of Medical Internet Research, Stellefson and colleagues reviewed the planning, implementation, and overall effectiveness of Web 2.0 self-management interventions for older adults with one or more chronic diseases.

The authors identified 15 high-quality published studies, which were examined in depth. The findings were mixed; while Web 2.0 participants felt greater self-efficacy for managing their diseases and benefitted from communicating with health care providers and/or website moderators, few studies indicated statistically significant improvements in medication adherence, biological outcomes, or health care utilization.

See the complete article here:  Web 2.0 Chronic Desease Self-Management for Older Adults

Forward this issue of Loyalty Marketing Monthly to a colleage

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Can co-pay programs be used for drugs that require the physician to purchase the product and bill the patient’s insurance plan (buy and bill)?

Yes, PSKW’s specialty product team designs co-pay programs that can be easily implemented for drugs covered under medical benefits, including those drugs that require the physician to buy and bill for the product. Claims are generally submitted to the program with a copy of the Explanation of Benefits (EOB) that lists the amount owed by the patient after the primary insurance plan has paid. Payment is then provided via a signature-based debit card or a check. The process time frame depends on the time required for the primary payer to review and approve the claim. PSKW will process co-pay claims within two to five business days. Funds loaded on a debit card are available immediately.

Upcoming Loyalty/Adherence Conferences

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

EyeForPharma’s
10th Patient Summit USA
May 2-3, 2013
Philadelphia, PA
Patient Summit USA

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Health System Factors and Antihypertensive Adherence in a Racially and Ethnically Diverse Cohort of New Users
by Alyce Adams, et al

This January 2013 article in JAMA Internal Medicine reports on the relationships between race/ethnicity, specific health system factors, and early nonpersistence and nonadherence.

Nonwhite race was associated with early nonpersistence and nonadherence. However, racial/ethnic differences in non-adherence were appreciably attenuated when medication co-payment and mail-order pharmacy use were accounted for.

The authors conclude that “strategies designed to reduce patient co-payments, ease access to medications, and optimize the choice of initial therapy may be effective tools in narrowing persistent gaps in the use of these and other clinically effective therapies.”

See the complete article here:  Health System Factors and Adherence in a Diverse Cohort

Prescription Co-pay Offset Cards
by Dilip Phadnis, et al

This December 2012 publication from Alliance Life Sciences provides important guidance regarding the attitudes and experiences of hundreds of payers, patients, pharmacists, and physicians regarding co-pay cards. Bottom line: although many payers are not in favor of co-pay offsets, physicians, patients, and pharmacists like them and see many benefits:

• >70% of physicians and pharmacists stated that co-pay cards improved compliance and persistence
• ~40% of physicians say that they have prescribed a drug primarily because it has a co-pay program
• About 28% of patients have requested a specific medication because of a co-pay offer, and in these instances the MDs always agree to their requests
• One-third of patients get co-pay cards from their physicians, 28% mention mail, and 20% obtain online
• ~55% of MDs say they are giving more co-pay cards and less samples today compared with a year ago.

See the complete article here:  Prescription Co-pay Offset Cards

Patient-Centered Outcomes of a Value-Based Insurance Design Program for Patients with Diabetes
by Daniel Elliott, et al

Published on February 13, 2013 (ePub ahead of print) in Population Health Management, Elliott and colleagues evaluated the patient-centered outcomes of a VBID program that eliminated co-payments for diabetes-related medications and supplies for employees and dependents with diabetes at a large health system.

Patients reported a significant reduction in monthly out-of-pocket costs, which corresponded to a significant reduction in cost-related nonadherence from 41% to 17.5%. The findings suggest that VBID programs can accomplish the anticipated goals for medication utilization and are highly regarded by participants.

See the complete article here:  Patient-Centered Outcomes of a VBID Program

Forward this issue of Loyalty Marketing Monthly to a colleage

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Which type of co-pay offer do MDs prefer for patients – “pay no more than $XX” or “$XX Off”?

In a recent survey of 150 MDs, PSKW found that doctors generally prefer “pay no more than” offers. Although “$off” offers tend to generate more claims than a PNMT offer with a similar average benefit, a PNMT offer is geared to restrict benefit to areas where you haven’t already paid for good coverage and to focus benefit on areas where the MC landscape is not as favorable.

Upcoming Loyalty/Adherence Conferences

World Congress Summit to Improve Adherence and Enhance Patient Engagement
Mar 14-15, 2013
Philadelphia, PA
World Congress Adherence

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

EyeForPharma’s
10th Patient Summit USA
May 2-3, 2013
Philadelphia, PA
Patient Summit USA

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Offsetting Effects of Prescription Drug Use on Medicare’s Spending for Medical Services
by the Congressional Budget Office

This November 2012 publication from the Congressional Budget Office (CBO) actually reports on a groundbreaking shift in federal policy. For the first time ever, the CBO is officially recognizing that “people respond to changes in cost sharing by changing their consumption of prescription drugs.” Furthermore, the CBO notes that “most often, pharmaceuticals have the effect of improving or maintaining an individual’s health.” The combined result of these new findings is that CBO is changing its “estimating methodology” so that any shift in Medicare cost-sharing policy that is estimated to cause a 1% increase in RXs filled will also be estimated to cause a 0.2% decrease in Medicare’s spending on medical services.

See the complete article here:  Offsetting Effects of Prescription Drug Use

Pharmacists Advancing Medication Adherence: Moving Forward on a Solid Foundation
by the National Community Pharmacists Association

The National Community Pharmacists Association (NCPA) has released Moving Forward on a Solid Foundation: Year One Progress Report, which examines the success of the association’s strategic initiative Pharmacists Advancing Medication Adherence (PAMA). PAMA’s goal is to facilitate the ability of independent community pharmacists to provide adherence services as a core competency of the profession, equivalent to the dispensing process, by 2015. The report, which covers July 2011 through July 2012, outlines the tangible and measurable steps that are currently underway in furtherance of that objective.

See the complete article here:  Pharmacists Advancing Medication Adherence

Communication and Medication Refill Adherence
by Neda Ratanawongsa, et al

From the December 2012 issue of JAMA Internal Medicine, Ratanawongsa and colleagues evaluated the association between patient-rated quality of patient/HCP communication and medication adherence. The authors conclude that for each 10-point decrease in communication, the adjusted prevalence of poor adherence increased by 0.9%. Compared with patients offering higher ratings, patients who gave HCPs lower ratings for involving patients in decisions, understanding patients’ problems with treatment, and eliciting confidence and trust were more likely to have poor adherence.

See the complete article here:  Communication and Medication Refill Adherence

Forward this issue of Loyalty Marketing Monthly to a colleage

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

What are physicians’ most important drivers in the use of co-pay assistance programs?

PSKW just surveyed 150 MDs regarding their use of co-pay programs. When deciding whether to use a co-pay coupon for a specific patient, the two most important considerations to physicians were the cost of therapy and the patient’s ability to pay. The particular therapeutic class was not as strong a factor in the decision.

Upcoming Loyalty/Adherence Conferences

ExL’s 3rd Patient Adherence and Advocacy Summit
Feb 25-66, 2013
Philadelphia, PA
Patient Adherence Summit

World Congress Summit to Improve Adherence and Enhance Patient Engagement
Mar 14-15, 2013
Philadelphia, PA
World Congress Adherence

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

EyeForPharma’s
10th Patient Summit USA
May 2-3, 2013
Philadelphia, PA
Patient Summit USA

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Rethinking Adherence
by John Steiner

This October 2012 article from Annals of Internal Medicine notes upcoming changes to the Medicare Advantage Plan Star Ratings program, and links those changes to a challenge to practitioners and policy makers as they seek strategies to improve adherence. Steiner suggests three core concepts to replace common — but flawed — non-adherence assumptions: (1) Adherence is a cluster of behaviors, not a single construct; (2) Adherence must be measured, not inferred; and (3) Improving adherence requires coordinated care, not just individual effort.

See the complete article here: Rethinking Adherence

Medication Adherence of Patient Assistance Program Recipients: A Pilot Study
by Christian Conley and Peter Hughes

In this October 2012 report in Innovations in Pharmacy, Conley and Hughes evaluate medication adherence of prescription assistance program recipients at an inner-city clinic. They conclude that although PAPs are a resource that can help the uninsured obtain medications, access to free or low-cost medication and usual counseling should not be the only interventions. Instead, subsidized medication should be augmented with behavioral interventions that focus on the patient’s motivation to adhere to a specific medication regimen.

See the complete article here:  Medication Adherence of Patient Assistance Program Recipients

Structural Equation Modeling of the Proximal–Distal Continuum of Adherence Drivers
by Colleen McHorney, et al

From the November 2012 issue of Patient Preference and Adherence, McHorney and colleagues approach the adherence challenge by categorizing adherence drivers into three clusters: distal drivers (generic beliefs, states, and skills), intermediate drivers (disease-related states and skills), and proximal drivers (treatment-related beliefs). The authors conclude that interventions that focus on distal drivers should be deprioritized. Instead, they suggest that future adherence interventions should target persons who are deficit in the treatment-related beliefs that comprise the most important proximal determinants of adherence: perceived need for medication, perceived medication concerns, and perceived medication affordability.

See the complete article here:  Structural Equation Modeling of the Contiuum of Adherence Drivers

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Do email and mobile engagement programs really increase adherence?

Yes! PSKW recently launched a multi-intervention program for a dermatologic brand (derm brands have notoriously low refill rates). 3-month response:

So, it seems that technology can offer an important conduit to patients that can successfully remind them to stay on therapy.
Differences in age and gender showed no significant influence.

Upcoming Loyalty/Adherence Conferences

ExL’s 3rd Patient Adherence and Advocacy Summit
Feb 25-66, 2013
Philadelphia, PA
Patient Adherence Summit

World Congress Summit to Improve Adherence and Enhance Patient Engagement
Mar 14-15, 2013
Philadelphia, PA
World Congress Adherence

CBI’s 12th Annual Patient Adherence and Support Summit
April 29-30, 2013
Philadelphia, PA
Patient Adherence & Support

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States: A Systematic Review
by Meera Viswanathan, et al

This September 2012 article from Annals of Internal Medicine provides a meta-analysis of 67 published trials of 18 types of interventions intended to improve medication adherence for chronic diseases. The investigators found “robust evidence that reduced out-of-pocket expenses improved medication adherence across clinical conditions.” In addition, “case management” and “patient education with behavioral support” also improved adherence for more than one condition.

See the complete article here: Interventions to Improve Adherence

Association of Health Literacy With Medication Knowledge, Adherence, and Adverse Drug Events Among Elderly Veterans
by Hilary Mosher, et al

In this October 2012 article in Journal of Health Communications: International Perspectives, Mosher and colleagues examined the association of health literacy (defined as “word recognition and pronunciation using health-related vocabulary”) with medication knowledge, adherence, and adverse drug events among veterans age >65. The authors found “no significant association between health literacy and adherence.”

See the complete article here: Association of Health Literacy With Medication Adherence…

Dosing Frequency and Medication Adherence in Chronic Disease
by Craig Coleman, et al

From the September 2012 issue of Journal of Managed Care Pharmacy, Craig Coleman and colleagues confirm what seems commonsensical: patients taking oral meds for chronic diseases are more adherent to once-a-day dosing regimens than to 2-, 3-, or 4-times-a-day regimens. The authors report on their systematic meta-analysis of 51 independent studies.

See the complete article here: Dosing Frequency and Medication Adherence in Chronic Disease

Attending the Eyeforpharma Patient Summit Oct 29-30?
Save $300 by usingcode “PSKW300.” Plus, our own Bob Caprara & Chris Dowd will present on Tuesday, October 30: “Co-pay Programs in the Spotlight: Top Controversies Affecting Pharma Marketers.” Don’t miss it!

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

How does a “1st Rx free” offer affect MD and patient behavior?

In general, a “1st free” offer is more likely to modify physician behavior, which should be an important goal of any program. MDs seem more willing to use “1st free” coupons, and they help drive trial and (hopefully) adoption. But “1st free” is not the best offer if the goal is patient persistency! A flat, PNMT offer where the patient receives a constant benefit for staying on therapy appears better suited to modifying patient behavior.

Upcoming Loyalty/Adherence Conferences

Eyeforpharma’s 9th Annual Patient Summit USA
Oct 29-30, 2012
Philadelphia, PA
Patient Summit USA

ExL’s 3rd Patient Adherence and Advocacy Summit
Feb 25-66, 2013
Philadelphia, PA
Patient Adherence Summit

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- ePrescription Co-pay Offers
- Universal Pharmacy Offers
- and more!

E-prescribing Shown to Improve Outcomes, Save Billions
by Journal Staff

This 2012 article in Health Management Technology links e-prescribing to a significant increase in first-fill medication adherence. According to the report, researchers at the nation’s largest health information network collaborated with pharmacies and pharmacy benefit managers to quantify the benefits of e-prescribing. The team analyzed de-identified data sets representing over 40 million prescription records,comparing electronic prescriptions with paper, phoned, and faxed prescriptions. The data showed a consistent 10% increase in first-fill adherence among physicians who adopted e-prescribing technology when compared with physicians who did not use e-prescribing.

See the complete article here: E-prescribing Shown to Improve Outcomes, Save Billions

The Effect of Reminder Systems on Patients’ Adherence to Treatment
by Sarah Fenerty, et al

In this 2012 article in Patient Preference and Adherence, Fenerty and colleagues provide a meta-analysis of eleven randomized controlled trials of reminder interventions to assist patient adherence to prescribed medications. The authors found a statistically significant increase in adherence in groups receiving a reminder intervention compared to controls.

See the complete article here: The Effect of Reminder Systems on Patients’ Adherence

Letting the Facts Get in the Way
by Mason Tenaglia

In this 2012 Pharmaceutical Executive article, Mason Tenaglia provides evidence that co-pay offset programs significantly boost patient adherence. Furthermore, studies have shown that increased patient adherence can reduce patient hospitalization rates, curb medical costs for insurers, and improve treatment outcomes.

See the complete article here: Letting the Facts Get in the Way

“Ask the Expert” by Bob Caprara, PSKW Chief Methodologist

Which is a better co-pay assistance offer – “pay no more than $XX” or “$XX Off”?

In general, a $off offer generates more claims than a PNMT offer with a similar average benefit because more people can use it, and a subset of patients will get the drug for free (nothing works better than free). However, a PNMT offer is geared to restrict benefit to areas where you haven’t already paid for good coverage and to focus benefit on areas where the MC landscape is not as favorable. So a PNMT offer is geared to leveling an unfavorable MC playing field.

Upcoming Loyalty/Adherence Conferences

ExL’s 6th Annual Digital Pharma East, Oct 15-18Philadelphia, PA Digital Pharma East

Eyeforpharma’s 9th Annual Patient Summit USA, Oct 29-30Philadelphia, PA Patient Summit USA

What We Do

Co-pay Assistance Initiatives

- Tangible Vehicles
- Virtual Vehicles

Digital Relationship Tools

- Loyalty Card Key
- Time-Release Messaging
- Engaged Patient
- Personalized One2One
- and more!